Skip to main content

Advertisement

Log in

11-Nor-9-carboxy-∆9-tetrahydrocannabinol quantification in human oral fluid by liquid chromatography–tandem mass spectrometry

  • Research Paper
  • Published:
Analytical and Bioanalytical Chemistry Aims and scope Submit manuscript

Abstract

Currently, ∆9-tetrahydrocannabinol (THC) is the analyte quantified for oral fluid cannabinoid monitoring. The potential for false-positive oral fluid cannabinoid results from passive exposure to THC-laden cannabis smoke raises concerns for this promising new monitoring technology. Oral fluid 11-nor-9-carboxy-∆9-tetrahydrocannabinol (THCCOOH) is proposed as a marker of cannabis intake since it is not present in cannabis smoke and was not measureable in oral fluid collected from subjects passively exposed to cannabis. THCCOOH concentrations are in the picogram per milliliter range in oral fluid and pose considerable analytical challenges. A liquid chromatography–tandem mass spectrometry (LCMSMS) method was developed and validated for quantifying THCCOOH in 1 mL Quantisal-collected oral fluid. After solid phase extraction, chromatography was performed on a Kinetex C18 column with a gradient of 0.01 % acetic acid in water and 0.01 % acetic acid in methanol with a 0.5-mL/min flow rate. THCCOOH was monitored in negative mode electrospray ionization and multiple reaction monitoring mass spectrometry. The THCCOOH linear range was 12–1,020 pg/mL (R 2 > 0.995). Mean extraction efficiencies and matrix effects evaluated at low and high quality control (QC) concentrations were 40.8–65.1 and −2.4–11.5 %, respectively (n = 10). Analytical recoveries (bias) and total imprecision at low, mid, and high QCs were 85.0–113.3 and 6.6–8.4 % coefficient of variation, respectively (n = 20). This is the first oral fluid THCCOOH LCMSMS triple quadrupole method not requiring derivatization to achieve a <15 pg/mL limit of quantification. The assay is applicable for the workplace, driving under the influence of drugs, drug treatment, and pain management testing.

Multiple reaction monitoring ion chromatograms for THCCOOH quantifier and qualifier transitions: from a blank oral fluid sample (A and B), blank oral fluid fortified at the 12 pg/mL limit of quantification (C and D) and an authentic specimen containing 26 pg/mL THCCOOH collected 0.25 h after 5 mg oral Marinol (E andF)

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Drummer OH (2006) Drug testing in oral fluid. Clin Biochem Rev 27(3):147–159

    Google Scholar 

  2. Bosker WM, Huestis MA (2009) Oral fluid testing for drugs of abuse. Clin Chem 55(11):1910–1931

    Article  CAS  Google Scholar 

  3. Langel K, Engblom C, Pehrsson A, Gunnar T, Ariniemi K, Lillsunde P (2008) Drug testing in oral fluid-evaluation of sample collection devices. J Anal Toxicol 32(6):393–401

    Article  CAS  Google Scholar 

  4. Huestis MA, Verstraete A, Kwong TC, Morland J, Vincent MJ, De La Torre R (2011) Oral fluid testing: promises and pitfalls. Clin Chem 57(6):805–810

    Article  CAS  Google Scholar 

  5. Wood M, Laloup M, Ramirez Fernandez Mdel M, Jenkins KM, Young MS, Ramaekers JG, De Boeck G, Samyn N (2005) Quantitative analysis of multiple illicit drugs in preserved oral fluid by solid-phase extraction and liquid chromatography-tandem mass spectrometry. Forensic Sci Int 150(2–3):227–238

    Article  CAS  Google Scholar 

  6. Substance Abuse and Mental Health Services Administration (2012) Results from the 2011 National Survey on Drug Use and Health: Summary of National Findings. NSDUH Series H-44. U.S. Department of Health and Human Services, Rockville

    Google Scholar 

  7. Matsunaga T, Iwawaki Y, Watanabe K, Yamamoto I, Kageyama T, Yoshimura H (1995) Metabolism of delta-9-tetrahydrocannabinol by cytochrome P450 isozymes purified from hepatic microsomes of monkeys. Life Sci 56:2089–2095

    Article  CAS  Google Scholar 

  8. Watanabe K, Yamaori S, Funahashi T, Kimura T, Yamamoto I (2007) Cytochrome P450 enzymes involved in the metabolism of tetrahydrocannabinols and cannabinol by human hepatic microsomes. Life Sci 80(15):1415–1419

    Article  CAS  Google Scholar 

  9. Huestis MA, Cone EJ (2004) Relationship of delta 9-tetrahydrocannabinol concentrations in oral fluid and plasma after controlled administration of smoked cannabis. J Anal Toxicol 28(6):394–399

    Article  CAS  Google Scholar 

  10. Lee D, Schwope DM, Milman G, Barnes AJ, Gorelick DA, Huestis MA (2012) Cannabinoid disposition in oral fluid after controlled smoked cannabis. Clin Chem 58(4):748–756

    Article  CAS  Google Scholar 

  11. Milman G, Schwope DM, Gorelick DA, Huestis MA (2012) Cannabinoids and metabolites in expectorated oral fluid following controlled smoked cannabis. Clin Chim Acta 413(7–8):765–770

    Article  CAS  Google Scholar 

  12. Niedbala S, Kardos K, Salamone S, Fritch D, Bronsgeest M, Cone EJ (2004) Passive cannabis smoke exposure and oral fluid testing. J Anal Toxicol 28(7):546–552

    Article  CAS  Google Scholar 

  13. Niedbala RS, Kardos KW, Fritch DF, Kunsman KP, Blum KA, Newland GA, Waga J, Kurtz L, Bronsgeest M, Cone EJ (2005) Passive cannabis smoke exposure and oral fluid testing. II. Two studies of extreme cannabis smoke exposure in a motor vehicle. J Anal Toxicol 29(7):607–615

    Article  CAS  Google Scholar 

  14. Moore C, Coulter C, Uges D, Tuyay J, van der Linde S, van Leeuwen A, Garnier M, Orbita J Jr (2011) Cannabinoids in oral fluid following passive exposure to marijuana smoke. Forensic Sci Int 212(1–3):227–230

    Article  CAS  Google Scholar 

  15. Lee D, Milman G, Barnes AJ, Goodwin RS, Hirvonen J, Huestis MA (2011) Oral fluid cannabinoids in chronic, daily cannabis smokers during sustained, monitored abstinence. Clin Chem 57(8):1127–1136

    Article  CAS  Google Scholar 

  16. Lee D, Karschner EL, Milman G, Barnes AJ, Goodwin RS, Huestis MA (2012) Can oral fluid cannabinoid testing monitor medication compliance and/or cannabis smoking during oral THC and oromucosal Sativex administration? Drug Alcohol Depend. doi:10.1016/j.drugalcdep.2012.10.011, epub ahead of print

    Google Scholar 

  17. Milman G, Barnes AJ, Schwope DM, Schwilke EW, Darwin WD, Goodwin RS, Kelly DL, Gorelick DA, Huestis MA (2010) Disposition of cannabinoids in oral fluid after controlled around-the-clock oral THC administration. Clin Chem 56(8):1261–1269

    Article  CAS  Google Scholar 

  18. Moore C, Coulter C, Rana S, Vincent M, Soares J (2006) Analytical procedure for the determination of the marijuana metabolite 11-nor-delta9-tetrahydrocannabinol-9-carboxylic acid in oral fluid specimens. J Anal Toxicol 30(7):409–412

    Article  CAS  Google Scholar 

  19. Milman G, Barnes AJ, Lowe RH, Huestis MA (2010) Simultaneous quantification of cannabinoids and metabolites in oral fluid by two-dimensional gas chromatography mass spectrometry. J Chromatogr A 1217(9):1513–1521

    Article  CAS  Google Scholar 

  20. Day D, Kuntz DJ, Feldman M, Presley L (2006) Detection of THCA in oral fluid by GC-MS-MS. J Anal Toxicol 30(9):645–650

    Article  CAS  Google Scholar 

  21. Coulter C, Garnier M, Moore C (2012) Analysis of tetrahydrocannabinol and its metabolite, 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid, in oral fluid using liquid chromatography with tandem mass spectrometry. J Anal Toxicol 36(6):413–417

    Article  CAS  Google Scholar 

  22. Lee PD, Chang YJ, Lin KL, Chang YZ (2012) Simultaneous determination of delta9-tetrahydrocannabinol and 11-nor-9-carboxy-delta9-tetrahydrocannabinol in oral fluid using isotope dilution liquid chromatography tandem mass spectrometry. Anal Bioanal Chem 402(2):851–859

    Article  CAS  Google Scholar 

  23. He X, Kozak M, Nimkar S (2012) Ultra-sensitive measurements of 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid in oral fluid by microflow liquid chromatography-tandem mass spectrometry using a benchtop quadrupole/orbitrap mass spectrometer. Anal Chem 84(18):7643–7647

    Article  CAS  Google Scholar 

  24. Krouwer JS, Rabinowitz R (1984) How to improve estimates of imprecision. Clin Chem 30(2):290–292

    CAS  Google Scholar 

  25. Matuszewski BK, Constanzer ML, Chavez-Eng CM (2003) Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Anal Chem 75(13):3019–3030

    Article  CAS  Google Scholar 

  26. Milman G, Schwope DM, Schwilke EW, Darwin WD, Kelly DL, Goodwin RS, Gorelick DA, Huestis MA (2011) Oral fluid and plasma cannabinoid ratios after around-the-clock controlled oral delta9-tetrahydrocannabinol administration. Clin Chem 57(11):1597–1606

    Article  CAS  Google Scholar 

  27. Quintela O, Andrenyak DM, Hoggan AM, Crouch DJ (2007) A validated method for the detection of delta(9)-tetrahydrocannabinol and 11-nor-9-carboxy-delta(9)-tetrahydrocannabinol in oral fluid samples by liquid chromatography coupled with quadrupole-time-of-flight mass spectrometry. J Anal Toxicol 31(3):157–164

    Article  CAS  Google Scholar 

  28. Moore C, Rana S, Coulter C, Day D, Vincent M, Soares J (2007) Detection of conjugated 11-nor-delta9-tetrahydrocannabinol-9-carboxylic acid in oral fluid. J Anal Toxicol 31(4):187–194

    Article  CAS  Google Scholar 

Download references

Acknowledgments

This research was supported by the Intramural Research Program of the National Institute on Drug Abuse, National Institutes of Health.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Marilyn A. Huestis.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Scheidweiler, K.B., Himes, S.K., Chen, X. et al. 11-Nor-9-carboxy-∆9-tetrahydrocannabinol quantification in human oral fluid by liquid chromatography–tandem mass spectrometry. Anal Bioanal Chem 405, 6019–6027 (2013). https://doi.org/10.1007/s00216-013-7027-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00216-013-7027-6

Keywords

Navigation